| Business Summary | | Response
Oncology,
Inc.
is
a
comprehensive
cancer
management
company.
The
Company
provides
advanced
cancer
treatment
services
through
outpatient
facilities,
known
as
Impact
Centers,
under
the
direction
of
practicing
oncologists;
owns
the
assets
of
and
manages
the
non-medical
aspects
of
oncology
practices;
compounds
and
dispenses
pharmaceuticals
to
certain
oncologists
for
a
fixed
or
cost
plus
fee,
and
conducts
outcomes
research
on
behalf
of
pharmaceutical
manufacturers.
Approximately
300
medical
oncologists
are
associated
with
the
Company
through
these
programs.
On
March
29,
2001,
the
Company
and
its
wholly
owned
subsidiaries,
Response
Oncology
Management
of
South
Florida,
Inc.,
Response
Oncology
of
Fort
Lauderdale,
Inc.
and
Response
Oncology
of
Tamarac,
Inc.,
filed
voluntary
petitions
for
reorganization
under
Chapter
11
of
the
United
States
Bankruptcy
Code. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | ROIX
is
a
comprehensive
cancer
management
company
that
provides
advanced
cancer
treatment
services,
manages
the
practices
of
oncologists,
and
conducts
cancer
research
on
behalf
of
pharmaceutical
companies.
For
the
six
months
ended
6/30/01,
revenues
fell
11%
to
$62.5
million.
Net
loss
totaled
$2.1
million,
up
from
$416
thousand.
Results
reflect
the
termination
of
a
certain
Service
Agreement
and
increased
legal,
accounting
and
reorganization
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| William West, M.D., 53 Chairman | -- | Anthony LaMacchia, 47 Pres,
CEO, Director | $479K | Frank Bumstead, 59 Vice
Chairman | -- | Peter Stark CFO, Exec. VP | 179K | Patrick McDonough COO,
Exec. VP | 193K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|